Product Data Sheet

Diflomotecan

Catalog No. A57127

main product photo
Diflomotecan is a potent inhibitor of topoisomerase I, exhibiting strong oral bioavailability. It demonstrates enhanced plasma stability and superior preclinical anti-tumor activity compared to established compounds. This makes Diflomotecan a valuable tool for cancer research and therapeutic development targeting topoisomerase I pathways.
Chemical Information
Catalog NumA57127
M. Wt398.36
FormulaC21H16F2N2O4
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.220997-97-7
SynonymsBN 80915
SMILESO=C(OC1)C[C@](O)(CC)C2=C1C(N3CC4=CC5=CC(F)=C(F)C=C5N=C4C3=C2)=O
Biological Activity
DescriptionDiflomotecan is a potent inhibitor of topoisomerase I, exhibiting strong oral bioavailability. It demonstrates enhanced plasma stability and superior preclinical anti-tumor activity compared to established compounds. This makes Diflomotecan a valuable tool for cancer research and therapeutic development targeting topoisomerase I pathways.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.